This story has been corrected to clarify that Compugen received orders from Prot@gen and not Protogene.

NEW YORK, Dec 1 – Compugen said Friday it had received orders from Pfizer and Prot@gen of Germany for its Z3 proteomics software and expects to announce several more commercial users in the near future.

“Several pharmas are acquiring the product and we expect that by the end of the year we will have six or seven clients,” Lior Ma’ayan, vice president of commercial operations at Compugen, told GenomeWeb.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.